Australian Dairy Nutritionals (ASX:AHF): Placement and Cash Flow Developments

Aditi Sarkar

15 October 2026 08:18 PM AEDT

Australian Dairy Nutritionals (ASX:AHF): Placement and Cash Flow Developments

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

A strategic placement is structured to raise $500,000 before costs through three tranches.
Cash at 30 September 2026 was $513,000, following net operating cash use of $619,000.
September-quarter consolidated revenue was $870,000, with contrasting trends across business segments.
The company reported a fully drawn $1.5 million secured loan facility.
Vietnam product registration and further China distribution are relevant commercial developments.

Australian Dairy Nutritionals Limited (ASX:AHF) operates dairy farms and manufactures infant formula, nutritional powders and customised specialty dairy products in Victoria, according to its official website. Its October 2026 disclosures combine an equity placement with an update on cash consumption, revenue trends and overseas product distribution. These developments frame its funding needs.

Placement Terms and Funding Timetable

On 14 October 2026, Australian Dairy Nutritionals (ASX:AHF) announced a $500,000 placement before costs to existing substantial shareholder Fire Dragon Capital Pty Ltd. The company proposes to issue 28,901,735 fully paid ordinary shares at $0.0173 each. The announced issue price matched the 30-day volume-weighted average price to 9 October 2026; it is a transaction term rather than a current market quotation.

The placement comprises 11,560,694 shares for $200,000 expected on 15 October, another 11,560,694 shares for $200,000 expected on 26 October and 5,780,347 shares for $100,000 expected on 2 November 2026. The company intends to rely on its existing ASX Listing Rule 7.1 placement capacity and apply for quotation of the new shares. These dates remain indicative.

Australian Dairy Nutritionals (ASX:AHF) said proceeds are intended for operations and working capital. It also described discussions concerning possible additional funding, but no further placement was confirmed in the announcement. Issuing additional ordinary shares increases the share count and changes existing shareholders’ proportional ownership.

September Quarter Liquidity Position

The company’s Appendix 4C reported net cash used in operating activities of $619,000 for the quarter ended 30 September 2026. Cash at the quarter end was $513,000, compared with approximately $1.2 million at the end of FY26. The filing estimated 0.83 quarters of funding available on its reported measures, emphasising why timing and receipt of financing matter for near-term liquidity.

Australian Dairy Nutritionals (ASX:AHF) also reported a secured 12-month loan facility of $1.5 million, drawn in full, carrying interest at 9.74% per annum. The loan is separate from the placement. The quarterly filing contains presentation differences between cash receipts and recognised revenue; those measures should not be treated as interchangeable or used to infer undisclosed profitability.

Revenue Mix and Overseas Distribution

September-quarter consolidated revenue was $870,000, a decline of 54% against the corresponding quarter and 66% against the final quarter of FY26, according to the company. Nutritional powders revenue was $164,000, down 87% on the corresponding period. Management attributed the movement to China distributor-order timing and a pause in Vietnam sales associated with product registration.

Farm revenue was $705,000, up 22% on the corresponding period. Australian Dairy Nutritionals (ASX:AHF) linked the change to an increased number of milking cows and favourable seasonal conditions. Segment results therefore moved in different directions, with farm sales providing a larger contribution to the quarter’s reported revenue.

The company reported 1,490 active Chinese retail outlets and a stated target of 2,000 by the end of FY27, subject to market conditions. It also reported Vietnam product registration and an expectation that sales would recommence from November 2026. Neither the outlet target nor the sales timetable should be presented as achieved results.

Key Insights

Australian Dairy Nutritionals (ASX:AHF) is addressing a limited quarter-end cash balance through a staged placement while its dairy and nutritional powders divisions display different revenue patterns. The extent of immediate liquidity improvement depends on completion of the proposed tranches, alongside ongoing operating cash requirements. Future company disclosures can clarify the receipt of funding, progress in overseas markets and the balance between cash expenditure and collections.

FAQs

Q: What does Australian Dairy Nutritionals produce?

A:The business manufactures infant formula and specialty dairy powders and operates dairy farming activities in Victoria.

Q: How much funding did ASX:AHF announce?

A:The company announced a three-tranche placement intended to raise $500,000 before costs.

Q: How much cash was reported at September quarter-end?

A:The reported cash balance at 30 September 2026 was $513,000.

Q: Did nutritional powders and farm revenue move in the same direction?

A:No. Nutritional powders revenue declined, while farm revenue increased on the corresponding period.

Q: Has the additional funding beyond the placement been confirmed?

A:No. The company referred to discussions regarding further funding without confirming another transaction.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.